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In recent years, genetic counseling has started playing a major role in the field of
genomic medicine. There are currently about 7,000 genetic counselors in more than
28 countries, with 267 certified genetic counselors in Japan alone (about 2 per million
population, as of April 2020). While the rapid advancement of genomic medicine has
expanded this field, the challenges genetic counselors face are also evolving. This article
aims to provide an overview of the institutional and social issues surrounding genetic
counselors in Japan and discuss implications for the global community. In Japan, with
the rapid changes in genomic medicine and the establishment of a delivery mechanism
within the healthcare system, several issues need to be discussed. First, many genetic
testing, counseling, and preventive healthcare programs are not covered by public
health insurance. Second, reducing human resource shortages for genetic counseling
is an urgent issue. Third, the lack of a national qualification in the profession is critically
important issue in the field. Fourth, research on the role and value of genetic counselors
is still limited. To address these issues, discussions among relevant stakeholders,
including genetic counselors, professionals in genomic medicine, and lawmakers, are
necessary. Additionally, we believe that research by genetic counselors to evaluate and
improve their practice and examine institutional and social issues is crucial for developing
their profession’s activities and delivering high-quality healthcare to many people. To
establish the position and role of the relatively new profession of genetic counselor,
sharing information and collaborating on institutional and social challenges faced by
genetic counselors globally will be beneficial.
Keywords: genetic counselor, genetic counseling, genomic medicine, national qualification, professional
development, research, workforce
INTRODUCTION
In recent years, genomics as a specialization in medicine has progressively expanded and attracted
attention. Genetic counselors play a major role in genomic medicine. The first genetic counseling
training program was established at the Sarah Lawrence College in New York, United States,
in 1969. There are about 7,000 genetic counselors in more than 28 countries, as of 2018
(Abacan et al., 2019).
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In Japan, there is a certification program called “Certified
Genetic Counselor” (CGC), which is a joint qualification
obtained under the Japan Society of Human Genetics and the
Japanese Society of Genetic Counseling (Japanese Board of
Genetic Counseling, 2010). To become a CGC, an individual
must graduate from a professional training program approved
by the Japanese Board of Genetic Counseling established
by the two societies and pass the certification examination.
Requirements for the professional training programs include
the following: a master’s degree must be awarded; clinical
geneticists and/or CGCs should be included in the faculty
in charge of the program; and the curriculum must meet
the achievement goals set by the Japanese Board of Genetic
Counseling. For 7 years from 1998 onward, a research group
funded by the national government began studying the training
of professionals involved in genetic medicine, including genetic
counselors; two training programs were established in 2003 and
one in 2004. The first certification examination was conducted
in 2005 by the Japanese Board of Genetic Counseling. In
designing these systems, that of the United States was used as
a reference. Its name was trademarked in 2019. In the almost
15 years since the CGC certification system was established
in 2005, it has faced many challenges—such as the lack of
acknowledgment as a national qualification and workforce issues
related to employment conditions suitable for a master’s degree—
as a relatively new profession in the medical field. Even as
genomic medicine has rapidly expanded, the challenges they face
are also evolving.
Globally, genetic counselors face various institutional and
social challenges in their work, and the situation varies across
countries (Balobaid et al., 2016; Abacan et al., 2019; Sun
et al., 2019; Pestoff et al., 2020). Although there are many
commonalities in practice, training curricula, certification, and
practice models vary among countries and depend on the
country’s healthcare system, laws, and regulations (Abacan et al.,
2019). We believe that an overview of the issues in Japan will
be not only useful in planning future strategies for improving
the quality of the genetic counseling delivery system but also
provide valuable information for those who are assessing possible
approaches to address issues regarding genetic counseling in
other countries. It is also important to share information on the
situation in various countries to stimulate global discussions on
common issues, such as the role that the profession needs to play
in future medicine. This article aims to provide an overview of
the institutional and social issues surrounding genetic counselors
in Japan and discuss its implications for the global community,
especially to utilize the expertise that genetic counselors have in
suitable situations.
OVERVIEW OF JAPAN’S HEALTHCARE
SYSTEM
Japan is an island country covering 377,974 square kilometers.
It is made up of 47 prefectures and has a population of about
126 million (Government of Japan, 2020), with most of the
population concentrated in metropolitan areas such as the capital
city, Tokyo. The Japanese medical service sector is based on a
universal health insurance system (Ministry of Health, Labour
and Welfare, 2012). Patients pay only a portion of their bills
for medical treatment (in most cases, the out-of-pocket rate is
30%), with the remaining charges being covered by insurance.
However, as a rule, individuals must bear the entire cost of
medical treatment when a part of it is not covered by insurance,
because the combination of public insurance and privately
paid treatment is not allowed except for in a few instances.
Medical reimbursements are reviewed and revised every 2 years
by the government.
Most medical professions are regulated by qualification
laws that define the permitted scope of work. To obtain a
license, individuals must complete a required curriculum at an
educational institution established in accordance with the law,
and pass a national examination. In Japan, these licenses for
healthcare workers are granted by Ministry of Health, Labour,
and Welfare. In this article, when referring to these systems, we
use the term “national qualification.”
There are several government organizations involved in
healthcare in Japan; the Ministry of Health, Labour, and Welfare
is mainly responsible for administration related to medical care
and welfare (Ministry of Health, Labour and Welfare, 2014).
In addition, the Ministry of Education, Culture, Sports, Science
and Technology is responsible for the education of medical
professionals and medical research (Ministry of Education,
Culture, Sports, Science and Technology, 2009).
RAPID CHANGES IN AND FUTURE
PERSPECTIVES ON GENOMIC
MEDICINE
In Japan, as in other countries, there have been rapid
advancements in genomic medicine, in line with advancements
in genome-wide analysis technology. These changes have been
particularly significant during the past few years, with the
implementation of various large-scale clinical studies and the
launch of new healthcare services related to genomic medicine.
In 2013, American actress Angelina Jolie announced that she
had hereditary breast and ovarian cancer syndrome (HBOC)
(Jolie, 2013). This caught the attention of many people across
the globe, including Japan. The publicity also led to an increased
interest in medical care for hereditary cancer, particularly HBOC,
among medical professionals. It offered a great opportunity to
discuss making medical services for hereditary cancer available
to more hospitals. Although most such medical services were
out-of-pocket at this point, it led to greater opportunities to
consider testing as an option. That year, a clinical study of
non-invasive prenatal genetic testing was also initiated in Japan
(Samura et al., 2017), and an active debate unfolded on the ideals
and pros and cons of such testing including varying opinions
regarding the possibility of choosing abortion and importance
of providing information about prenatal testing. This discussion
continues among various stakeholders, including healthcare
professionals, as well as their and patients’ organizations. Both
topics received extensive coverage and became major reasons
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for the recognition of genetic testing and counseling in society.
Mainly university hospitals had already established genetic
clinics, and the abovementioned events also led to an increase
in the number of general hospitals with genetic clinics. With the
aim of ensuring cooperation among the various clinical practice
sections of medical genetics, the National Liaison Council for
Clinical Sections of Medical Genetics was established in 2003. As
of 2021, a total of 132 medical institutions—including university
hospitals and other medical institutions—had joined (Fukushima
and Takada, 2020; National Liaison Council for Clinical Sections
of Medical Genetics, 2020).
There have been some major changes in healthcare in Japan
during the last few years. In 2018, one of the national healthcare
and research projects—known as “cancer genomic medicine,”
which utilizes cancer gene panel tests—began to develop a
healthcare delivery system for tumor profiling testing, which was
covered by public health insurance (Ebi and Bando, 2019). This,
in turn, prompted the need to establish a system to address
pathological variants in genes causing hereditary cancer on the
cancer gene panel, mainly called secondary findings. This should
include confirmatory germline testing and genetic counseling.
Efforts are being made to improve the system providing medical
care for rare diseases, including research projects of exome
analysis for undiagnosed diseases funded by the government. The
government has also been discussing the introduction of whole-
genome analysis for cancer as well as rare diseases mainly in
a research context since 2019 (Ministry of Health, Labour and
Welfare, 2019).
CURRENT CHALLENGES IN THE
IMPLEMENTATION OF GENOMIC
MEDICINE IN JAPAN
Challenges Related to the Delivery
System for Genomic Medicine
Genomic medicine requires the provision of individualized
prevention and treatment based on appropriate diagnoses for
individuals at risk, not merely those with symptoms. Improving
healthcare delivery and securing human resources are an
important factor in ensuring that such services are available to
those who need it.
In Japan, many genetic testing procedures, preventive
treatments, and surveillance mechanisms for unaffected
individuals are not covered by public health insurance (Aizawa
et al., 2020). With the advancement of genomic medicine,
the scope of medical care covered by public insurance is
gradually expanding, with various discussions and lobbying
endeavors by stakeholders. The BRCA1/2 genetic test was
already covered as a companion diagnosis for the PARP
inhibitor olaparib in 2018. As a result of the 2020 reforms in
the medical reimbursement system, the government committee
for national health insurance decided to extend the application
of genetic testing to individuals with a family history of HBOC
and breast and ovarian cancer patients. Further, reduced-risk
mastectomy or risk-reducing salpingo-oophorectomy for cancer
patients with BRCA1/2 associated HBOC are also covered
by insurance following these reforms. In the 2020 reforms in
the medical reimbursement system, the number of diseases
diagnosed by genetic testing covered by public insurance
increased by 65—that is, from 75 to 140 intractable diseases—
including genetic diseases occurring in children and intractable
diseases that are covered by the national subsidy system for
healthcare expenses (Table 1). Many genetic tests that are not
covered by insurance, such as Lynch syndrome and Familial
hypercholesterolemia, are conducted at patients’ own expense or
in the course of research. Under the national public insurance
system, genetic counseling is only covered by insurance if the
patient has undergone a genetic test that insurance permits,
and only a limited number of medical facilities are registered
to provide this genetic counseling. Prenatal genetic testing
and preimplantation diagnoses are not covered by national
health insurance. The availability of these services is limited.
Preimplantation diagnoses have been applied to disorders with
a high risk of seriously affecting children. The Japan Society
of Obstetrics and Gynecology and related stakeholders are
currently engaged in discussing the review system and the scope
of preimplantation diagnosis.
Therefore, some of the most crucial information that should
be provided to clients during genetic counseling concerns the
medical costs, including the genetic testing and the preventive
care. The burden of high medical costs outside of national
insurance for patients can be a factor in their hesitancy to pursue
genetic testing and preventive care, which can be frustrating for
medical professionals.
The scope of genetic counseling, including pre-symptomatic
patients, continues to expand with the increasing number of
medically actionable genetic disorders and the possibility of
tumor profiling tests, which can reveal that a patient has an
inherited form of cancer. The extent to which genomic medicine
should be included in insurance coverage requires further
discussion, with reference to the situation in other countries that
are actively promoting genomic medicine.
Challenges Related to the Growing Need
for Genetic Counseling Professionals
There is also an urgent need for training of professionals
for genetic counseling. Although there are no official data
available, the number of genetic counseling cases has steadily
increased nationwide during the last decade. This has led
to an increase in the number of medical professionals who
provide genetic counseling. Educating and supporting other
healthcare professionals has also become an important activity
for genetic counseling professionals, as genomic information
is increasingly handled in clinical practice. Genetic counseling
professionals have played a central role in the advancement
of genomic medicine, including efforts to establish academic
societies and organizations related to genomic medicine
(Fukushima and Takada, 2020). Through the efforts of relevant
stakeholders, mainly academic societies, basic knowledge
related to genetics has been introduced into the curricula
of medical school.
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TABLE 1 | Reimbursement for genetic testing and genetic counseling in Japan.
Revised year Diseases covered Medical service fees of genetic testing (Yen) Additional fees of genetic counseling (Yen)
2008 13 20,000 5,000
2010 15 40,000 5,000
2012 36 40,000 5,000
2014 36 38,800 5,000
2016 72 38,800 5,000
2018 75 38,800/50,000/80,000*1 10,000
2020 140*2 38,800/50,000/80,000*1 10,000
∗1Categories are defined by interactive disease.
∗2BRCA1/2 genetic testing (202,000 Yen) for the diagnosis of hereditary breast cancer ovarian cancer syndrome is not included here because it is in a separate category.
In Japan, 1,410 clinical geneticists who are physicians (about
11 per million population, as of July 2020) (Japanese Board of
Medical Genetics and Genomics Clinical Genetics, 2015) and 267
CGC who are not physicians (about 2 per million population,
as of April 2020) (Japanese Board of Genetic Counseling, 2010)
have been listed as genetic counseling professionals in the
“Guidelines for Genetic Tests and Diagnoses in Medical Practice”
by the Japanese Association of Medical Sciences (2011). The
same guidelines state that genetic testing for diagnostic purposes
in affected patients should, in principle, be handled by the
primary physician, and that genetic counseling is necessary for
pre-symptomatic patients or those with a prenatal diagnosis
(Japanese Association of Medical Sciences, 2011). In addition, the
existence of genetic counseling professionals is essential for the
abovementioned “cancer genome medicine.” Requirements for
medical facilities to provide insured tumor profile testing, which
is designated by the Ministry of Health, Labour, and Welfare,
include having at least one physician and one or more expert with
genetic counseling skills in the department that provides genetic
counseling services (Director of the Health Bureau, Ministry of
Health, Labour and Welfare, 2019).
Training genetic counseling professionals has not been able
to keep up with the rapid growth in demand. Owing to the
practical difficulties of training numerous people at once, each
graduate school can only train a few people per year, which
results in a shortage of genetic counselors. Further collaboration
between stakeholders is necessary, as there is a need to improve
the system to provide high-quality genetic counseling promptly
to those who need it.
THE POSITION OF GENETIC
COUNSELORS IN THE HEALTHCARE
SYSTEM AND THE MOVEMENT
TOWARD A NATIONAL QUALIFICATION
A critical challenge faced by the genetic counseling industry
in Japan is the professional qualification of genetic counselors.
While other medical professions specializing in genomic
medicine—including physicians and nurses—have a national
qualification to pursue, CGC is not yet a national qualification
but a certification accredited by academic societies. This means
that the scope of genetic counselors in the context of the Japanese
healthcare system is unclear, whereas the scope of practice of
other nationally qualified professionals is clearly defined by law.
When the current CGC certification system was established
in Japan, it had considerably little recognition in the medical
field and offered few opportunities for employment (Kohzaki,
2014). However, the demand for genetic counselors, especially
in clinical practice, has grown rapidly, owing to various changes
in genomic medicine and genetic counseling in recent years.
There is an overwhelming shortage of personnel to meet the
demand. There are also regional differences in placement, with
many jobs and employment opportunities available in urban
areas, and no genetic counselors at all in some prefectures.
Further, while the number of job opportunities for genetic
counselors has been increasing, especially in the last few years,
applications in rural areas are often lacking. Approximately 40%
of genetic counselors live or work in the densely populated
prefectures such as Tokyo, Aichi, and Osaka. The number of
training programs accredited by the Japanese Board of Genetic
Counseling has been increasing gradually, and that of new CGCs
is also rising annually. As of April 2020, there were 20 training
programs across the country, of which 19 were established as
master’s programs and only one as a doctoral program (Japanese
Board of Genetic Counseling, 2010). The locations of these
programs are also imbalanced. Among the 20 programs, about
half are in the three large metropolitan areas, Kanto, Tokai,
and Kansai which include prefectures of Tokyo, Aichi, and
Osaka, respectively.
Globally, the state of genetic counselor certification,
legislation, and licensing systems vary. Countries with national
and state regulations are limited, such as South Africa, Malaysia,
and parts of the United States; Australia is currently lobbying
for the regulation of the profession (Ormond et al., 2018;
Abacan et al., 2019). In Japan, there have been discussions
on national qualifications since the establishment of the
certification system by academic societies; however, this is
yet to be accomplished. Although many medical professions
became national qualifications because of laws developed after
World War II, it is not easy for new professions to become
national qualifications. In Japan, it took about 50 years of
debate to institute the national qualification of “certified public
psychologists,” whose primary job is to provide psychological
support. There has been little public discussion on the national
qualification of genetic counselors. However, the final report
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based on the interim report of the Council for the Promotion
and Realization of Genome Medicine, which was established
within the Office of Healthcare Policy of the Prime Minister
of Japan and His Cabinet, stated that the need for national
qualifications for genetic counselors should continue to be
considered, while considering the progress made in the field
of genomic medicine, as a long-term issue (Council for the
Promotion and Realization of Genome Medicine, 2019). One
of the three proposals in the “Development of Systems and
Human Resource for Promoting Genomic Medicine” proposal
issued by the Clinical Genome Medicine Subcommittee of the
Science Council of Japan (2020) is the national qualification of
genetic counselors.
With the abovementioned advancements in genomic
medicine, the role of the genetic counselor is expanding,
as opportunities to handle genome-wide information and
areas of engagement are also expanding. The nature of
the counselor’s work is changing from genetic to genomic
counseling (Patch and Middleton, 2019). There are also certain
difficulties because of the varying roles required in different
facilities and the lack of professional independence in the
system; this emphasizes the urgent necessity of establishing a
system that is responsive to demand and ensures consistent
expertise and quality. There are several issues that need
to be considered, such as securing the number of genetic
counselors to meet the needs of the field. In particular, to
establish a national qualification for genetic counselors,
it is necessary to implement a qualification law; to this
end, further encouragement by the relevant stakeholders,
including genetic counselors, is required. Discussions need
to continue with various stakeholders, including government
officials and lawmakers.
INCREASING THE CAPACITY FOR
RESEARCH AS THE NEXT CHALLENGE
FOR GENETIC COUNSELORS
Another challenge for genetic counselors is increasing their
capacity to carry out research, as many genetic counselors
work in clinical settings. In the United States, there has been
an increase in the proportion of genetic counselors working
in non-clinical settings such as testing companies, training
programs, and research institutions (Cohen and Tucker, 2018).
In Japan, there are a few genetic counselors working in non-
clinical settings, and many genetic counselors are involved
in various concurrent jobs. While many genetic counselors
are working in teams on research projects such as clinical
studies, there are only a few genetic counselors whose primary
job is research.
However, to develop activities as part of the genetic counseling
profession, it is necessary to evaluate and improve practice.
Simultaneously, institutional and social issues—such as the
position of the profession in collaboration with multiple
professions and the regulation of qualifications—need to
be considered. To implement these things, we believe that
research is a powerful tool that can capture and evaluate
phenomena from an objective standpoint and consider issues and
identify solutions.
The importance of genetic counselors conducting research has
already been highlighted (Biesecker, 2018). National Society of
Genetic Counselors (2018)—the main professional association of
genetic counselors in North America—has also listed research
as one of the areas of focus for its Strategic Plan 2019–2021.
Moreover, there have been world conferences since 2017 to
discuss empirical research on genetic counseling, which have
been attended by genetic counselors from across the globe
(Middleton et al., 2019).
The Japanese Association of Certified Genetic Counselors
clearly states in its Code of Ethics that research is one of its duties
“to contribute to the development of professional knowledge
and skills as a CGC through efforts in practice, research and
education” (Japanese Board of Genetic Counseling, 2010).
Although only little has been discussed on the significance
of the involvement of genetic counselors in research in
Japan, many genetic counselors are already conducting
research in various fields such as genetic counseling and
genomic medicine, and are actively making presentations at
academic conferences and publishing articles. The research areas
and subjects are gradually expanding, including research
involving clients who have received genetic counseling
(Yotsumoto et al., 2016; Watanabe et al., 2017) and studies
on healthcare professionals, including genetic counselors
(Yoshida et al., 2020).
However, few studies in Japan have examined the institutional
and social issues surrounding genetic counselors, such as
workforce issues, evaluation of genetic counseling by the public,
and its cultural impact. There is limited information, such as
published statistical data, on these issues. Many of them are
also written in Japanese. There is limited information from
other countries, especially those with a short history of genetic
counselors. We believe that expanding these areas of studies
will be useful in promoting an understanding of the genetic
counseling profession among stakeholders such as healthcare
policymakers. Future developments in this area are desirable,
including collaboration with researchers in other countries, as a
certain number of samples and experience will be necessary to
conduct research in these areas.
As more and more healthcare professionals begin to
get involved in genomic medicine, genetic counselors with
specialized training programs in genetic counseling will become
increasingly important in the future. As this occupation has a
short history, in Japan and many other countries, it will be
necessary to consider various aspects to make improvements in
the future. We hope that genetic counselors will take various
research initiatives and report their findings both domestically
and internationally. This will stimulate discussions on various
issues and lead to the development of the field.
CONCLUSION
In Japan, genetic counseling is new, compared with many other
healthcare professions. This means that there are also many
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institutional and social challenges surrounding the profession
and the necessity for it to respond to a rapidly growing need
among patients. During the past 15 years, the foundation of
the profession has been laid based on precedents from both
Japan and abroad, and it appears that genetic counselors are
moving to the next step in their development as a profession,
which will support the future of medical care and deliver high-
quality genetic counseling to those who need it. Although there
are differences in the medical systems and cultural backgrounds
of all countries, we can learn a lot from the variety of efforts
in other countries, such as how to tackle workforce issues
and improve the quality of genetic counseling. Therefore, it
will be important for Japanese genetic counselors to take the
initiative in promoting discussion and creating a professional
role in genomic medicine, while drawing inspiration from their
global colleagues.
Ormond et al. (2018) stated that, as the role of
genetic counselors is becoming more diverse in the
era of precision medicine, they can learn from each
other and share experiences, which they can apply
to their own national context. Through research and
other activities, sharing institutional and social challenges
faced by genetic counselors in various countries and
communicating with them will be beneficial for the development
of the profession.
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